Dmfp task order no. 6 kenny BPN 19302
Ended Awarded Last action
- Contract number
- HHSN27100006
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $214,668
Award facts
- Contract value 98% obligated
-
- $214,667.73 Current, with exercised options
- $219,167.73 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$18,000 | |
| Funding Only Action | -$19,870 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $18,000 | |
| Original award | $234,538 |
About this award
This is a delivery order award to Curia Global Inc., doing business as Amri, under the Drug Manufacturing and Formulation Program (DMFP) IDIQ contract with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The $219,167.73 cost-plus-fixed-fee award has a performance period through September 24, 2024 and does not include a set-aside designation. Curia, a leading global contract development and manufacturing organization, will provide a range of pharmaceutical research and development services to NIDA, including medicinal chemistry, process chemistry, GMP manufacturing, and other support for initiatives related to neurology, infectious diseases, and substance abuse treatments. This award is part of Curia's extensive experience supporting various NIH institutes and other federal agencies through prime and subcontract awards focused on therapeutic development.
Quick answers
Who was awarded contract HHSN27100006?
HHSN27100006 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on December 1, 2017.
How much is contract HHSN27100006 worth?
The government has obligated $214,668 on HHSN27100006. Its potential value, with all options, is $219,168.
Is contract HHSN27100006 an order under another contract?
Yes. HHSN27100006 is a delivery order under HHSN271201500005I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).
Was contract HHSN27100006 competed?
The extent of competition for HHSN27100006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award